Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Z Yuan, Y Li, S Zhang, X Wang, H Dou, X Yu, Z Zhang… - Molecular cancer, 2023 - Springer
The malignant tumor is a multi-etiological, systemic and complex disease characterized by
uncontrolled cell proliferation and distant metastasis. Anticancer treatments including …

High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints

MA Lisio, L Fu, A Goyeneche, Z Gao… - International journal of …, 2019 - mdpi.com
Among a litany of malignancies affecting the female reproductive tract, that of the ovary is the
most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

NI Nissen, M Karsdal, N Willumsen - Journal of Experimental & Clinical …, 2019 - Springer
The extracellular matrix (ECM) plays an important role in cancer progression. It can be
divided into the basement membrane (BM) that supports epithelial/endothelial cell behavior …

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria… - Nature reviews …, 2015 - nature.com
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths,
and overall survival has not changed significantly for several decades. In this Opinion article …

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance

EA Pietilä, J Gonzalez-Molina… - Nature …, 2021 - nature.com
Due to its dynamic nature, the evolution of cancer cell-extracellular matrix (ECM) crosstalk,
critically affecting metastasis and treatment resistance, remains elusive. Our results show …

Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers

OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols… - Cancer discovery, 2018 - AACR
We have profiled, for the first time, an evolving human metastatic microenvironment by
measuring gene expression, matrisome proteomics, cytokine and chemokine levels …

miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers

AM Givel, Y Kieffer, A Scholer-Dahirel, P Sirven… - Nature …, 2018 - nature.com
High-grade serous ovarian cancers (HGSOC) have been subdivided into molecular
subtypes. The mesenchymal HGSOC subgroup, defined by stromal-related gene signatures …

Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation

GK Pandey, S Mitra, S Subhash, F Hertwig, M Kanduri… - Cancer cell, 2014 - cell.com
Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most
common extracranial tumor of childhood. By sequencing transcriptomes of low-and high-risk …

[HTML][HTML] Multiple roles for basement membrane proteins in cancer progression and EMT

S Banerjee, WC Lo, P Majumder, D Roy… - European Journal of …, 2022 - Elsevier
Metastasis or the progression of malignancy poses a major challenge in cancer therapy and
is the principal reason for increased mortality. The epithelial-mesenchymal transition (EMT) …